文献速递心脑血管急症

性别和种族是否影响急诊科急性冠脉综合征验前概率

Do Gender and Race Make a Difference in Acute Coronary Syndrome Pretest Probabilities in the Emergency Department?
PubMed 文献 · Acad Emerg Med · 2017-01-30
一句话结论女性和非白人患者的ACS主观及客观验前概率均显著低于对应群体,但ACS诊断率、胸部辐射剂量、30天费用和90天急诊返回率无显著差异。

本研究为一项前瞻性结局研究的二次分析,纳入844例急诊胸痛和呼吸困难患者,按性别(女性478/844,57%)和种族(非白人444/783,57%)分层,比较提供者视觉模拟量表(VAS)评估的ACS可能性、PREtest Consult计算的客观验前概率、ACS诊断率、胸部总辐射暴露、30天总费用和90天再就诊率。女性提供者VAS评分14%(95%CI 13%-16%)显著低于男性22%(95%CI 19%-24%),客观验前概率女性2.7%(95%CI 2.4%-3.1%)显著低于男性6.6%(95%CI 5.9%-7.3%);非白人VAS评分15%(95%CI 13%-16%)显著低于白人20%(95%CI 18%-23%),客观验前概率非白人3.4%(95%CI 2.9%-3.9%)显著低于白人5.3%(95%CI 4.7%-5.9%)。但女性与男性、非白人与白人在ACS诊断率、平均胸部辐射剂量、30天总费用和90天急诊返回率上均无显著差异。结论认为,尽管女性和少数族裔的ACS验前概率被一致低估,但未发现后续评估(辐射暴露和费用)显著减少,需进一步研究验前评估对急诊胸痛评估中性别和种族差异的影响。

要点

  • 女性提供者VAS评分14%(95%CI 13%-16%)显著低于男性22%(95%CI 19%-24%),客观验前概率女性2.7%(95%CI 2.4%-3.1%)显著低于男性6.6%(95%CI 5.9%-7.3%)。
  • 非白人提供者VAS评分15%(95%CI 13%-16%)显著低于白人20%(95%CI 18%-23%),客观验前概率非白人3.4%(95%CI 2.9%-3.9%)显著低于白人5.3%(95%CI 4.7%-5.9%)。
  • 女性与男性ACS诊断率3.6% vs 1.6%、平均胸部辐射剂量5.0 mSv vs 4.9 mSv、30天总费用$3,451.24 vs $3,847.68、90天急诊返回率26% vs 26%均无显著差异。
  • 非白人与白人ACS诊断率3.2% vs 2.4%、平均胸部辐射剂量4.6 mSv vs 5.0 mSv、费用$3,156.02 vs $2,885.18、90天急诊返回率28% vs 23%均无显著差异。
  • 尽管女性和少数族裔的ACS验前概率被一致低估,但未发现后续评估(辐射暴露和费用)显著减少。

适用人群与场景

  • 急诊科胸痛和呼吸困难患者,共844例,女性478/844(57%),非白人444/783(57%)。
  • 种族/民族信息完整者783例(93%)。

研究设计与关键结果

  • 研究类型:前瞻性结局研究的二次分析,样本量844例,女性478/844(57%),非白人444/783(57%)。
  • 女性提供者VAS评分14%(95%CI 13%-16%)显著低于男性22%(95%CI 19%-24%),p=0.000;客观验前概率女性2.7%(95%CI 2.4%-3.1%)显著低于男性6.6%(95%CI 5.9%-7.3%),p=0.000。
  • 非白人提供者VAS评分15%(95%CI 13%-16%)显著低于白人20%(95%CI 18%-23%),p=0.000;客观验前概率非白人3.4%(95%CI 2.9%-3.9%)显著低于白人5.3%(95%CI 4.7%-5.9%),p=0.000。
  • 女性与男性ACS诊断率3.6% vs 1.6%、平均胸部辐射剂量5.0 mSv vs 4.9 mSv、30天总费用$3,451.24 vs $3,847.68、90天急诊返回率26% vs 26%,均无显著差异。
  • 非白人与白人ACS诊断率3.2% vs 2.4%、平均胸部辐射剂量4.6 mSv vs 5.0 mSv、费用$3,156.02 vs $2,885.18、90天急诊返回率28% vs 23%,均无显著差异。

证据类型、等级与局限

  • 证据类型:前瞻性结局研究的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 女性和非白人患者的ACS主观及客观验前概率均显著低于对应群体,但ACS诊断率、胸部辐射剂量、30天费用和90天急诊返回率无显著差异,作者认为需进一步研究验前评估对急诊胸痛评估中性别和种族差异的影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: The objective was to test for significant differences in subjective and objective pretest probabilities for acute coronary syndrome (ACS) in a large cohort of chest pain patients stratified by race or gender. Secondarily we wanted to test for any differences in rates of ACS, rates of 90-day returns, cost, and chest radiation exposure after these stratifications.

METHODS: This is a secondary analysis of a prospective outcomes study of ED patients with chest pain and shortness of breath. We performed two separate analyses. The data set was divided by gender for analysis 1 while the analysis 2 stratification was made by race (nonwhite vs. white). For each analysis, groups were compared on several variables: provider visual analog scales (VAS) for likelihood of ACS, PREtest Consult ACS probabilities, rates of ACS, total radiation exposure to the chest, total costs at 30 days, and 90-day recidivism (ED, overnight observations, and inpatient admissions).

RESULTS: A total of 844 patients were studied. Gender information was present on all 844 subjects, while complete race/ethnicity information was available on 783 (93%) subjects. For the first analysis, female patients made up 57% (478/844) of the population and their mean provider VAS scores for ACS were significantly lower (p = 0.000) at 14% (95% confidence interval [CI] = 13% to 16%) than that of males at 22% (95% CI = 19% to 24%). This was consistent with the objective pretest ACS probabilities subsequently calculated via the validated online tool, PREtest Consult, which were also significantly lower (p = 0.000) at 2.7% (95% CI = 2.4% to 3.1%) for females versus 6.6% (95% CI = 5.9% to 7.3%) for males. However, comparing females to males, there was no significant difference in diagnosis of ACS (3.6% vs. 1.6%), mean chest radiation doses (5.0 mSv vs. 4.9 mSv), total costs at 30 days ($3,451.24 vs. $3,847.68), or return to the ED within 90 days (26% each). For analysis 2 by race, nonwhite patients also comprised 57% (444/783) of individuals. Similar to the gender analysis, mean provider VAS scores for ACS were found to be significantly lower (p = 0.000) at 15% (95% CI = 13% to 16%) for nonwhite versus 20% (95% CI = 18% to 23%) for white subjects. Concordantly, objective pretest ACS probabilities were also significantly lower (p = 0.000) at 3.4% (95% CI = 2.9% to 3.9%) for nonwhite versus 5.3% (95% CI = 4.7% to 5.9%) for white subjects. There were no significant differences in outcomes in nonwhite versus white subjects when compared on diagnosis of ACS (3.2% vs 2.4%), mean chest radiation dose (4.6 mSv vs. 5.0 mSv), cost ($3,156.02 vs. $2,885.18), or 90-day ED returns (28% vs. 23%).

CONCLUSIONS: Despite consistently estimating the risk for ACS to be lower for both females and minorities concordantly with calculated objective pretest assessments, there does not appear to have been any significant decrease in subsequent evaluation of these perceived lower-risk groups when radiation exposure and costs are taken into account. Further studies on the impact of pretest assessments on gender and racial disparities in ED chest pain evaluation are needed.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Musey PI, Kline JA. Do Gender and Race Make a Difference in Acute Coronary Syndrome Pretest Probabilities in the Emergency Department? Acad Emerg Med. 2017. PMID: 27862670. doi:10.1111/acem.13131

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。